Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: CytomX Therapeutics Inc., 3 years.
CytomX Therapeutics Inc.
Director
Cardiff Oncology Inc.
Director · Chief Executive Officer
Chief executive roles
Dates unknown
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Cardiff Oncology Inc. June 11, 2026100.0%
-
Cardiff Oncology Inc. June 26, 2025100.0%
-
CytomX Therapeutics Inc. June 11, 202569.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 14, 2026 | Cardiff Oncology Inc. | Open-market purchase | +34,364 | $1.46 | $50,000 |
| Jun 18, 2026 | Cardiff Oncology Inc. | Open-market purchase | +24,703 | $1.21 | $29,891 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.